Navident EVO Received FDA Approval: Revolutionizing Guided Endodontics and Minimally Invasive Dental Surgery

ClaroNav, a Canadian developer of surgical navigation and photogrammetry systems, has reached a major milestone after its Navident EVO system won expanded approval from the U.S. Food and Drug Administration (FDA). This approval extends to guided endodontics, which is expected to improve the effectiveness and accuracy of the complex dental surgeries and introduce less invasive procedures.

Data from Precedence Research indicates the global dental services market size accounted for USD 453.44 billion in 2023 and it is expected to hit around USD 731.59 billion by 2033, growing at a CAGR of 4.9% from 2024 to 2033.

Navident EVO is a revolutionary dental-surgical navigation system that enables visual guidance in real time during procedures, enhancing accuracy and efficiency. Navigation technology leads to better results in endodontic procedures and hard-tissue dental surgery with minimal discomfort for both the doctor and the patient.

The FDA’s newly extended approval permits the use of Navident EVO for guiding endodontics, which is a significant development in its functionalities. The system’s real-time navigational capabilities allow it to reach any calcified or obscured dental canals. This is important because it helps preserve the tooth structure, especially during complicated endodontic treatments. Navident EVO’s technique is so minimally invasive that a surgeon can carry out accurate operations using smaller cuts only, which minimizes the pain inflicted on the patient and enables quicker healing times.

Navident EVO’s other features aim to enhance precision using Cone-beam computed tomography (CBCT) scans within the system. Detailed pre-operative planning CBCT scans assist dentists in placing implants and performing endodontic surgeries more accurately and effectively. In addition to these factual capabilities, this technology also reduces the risk associated with surgery. It increases the expected positive outcome of the surgical procedure, increasing the level of trust and satisfaction of the patients.

The advantages offered by Navident EVO are not confined to just clinical accuracy. It also enhances the efficiency and manageability of complicated dental procedures by generating faster workflows. The plug-and-play design ensures that even new users take less time orienting themselves to the system, and the procedures become more consistent. ClaroNav has built Navident EVO to easily conform to how a dentist works or the existing system, thus ensuring that clinicians put all their time and resources to good use.

There are numerous patient-related benefits from the improved features of Navident EVO. Its minimally invasive techniques are associated with smaller incisions, less pain, and quick recovery times, hence better patient experiences. ClaroNav mentions that such technologies have been developed for the safety and comfort of patients undergoing complex dental procedures.

The incorporation of guided endodontics in the Navident EVO system is yet another proof of ClaroNav’s commitment to progress in surgical dentistry. The Navident EVO system profile highlights the possibilities that state-of-the-art dental technology can offer to access even the most difficult areas of the mouth with real-time navigation. It provides an effective tool for enhancing the precision and results of hard-tissue surgical procedures undertaken in dental practice, thus proving an important tool for endodontic practitioners. The expansion of ClaroNav’s technological realization enables us to expect more impact on the development of dental surgery and endodontics globally than ever before.

We’ve prepared a service to support you. Please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344